Package 51662-1363-1

Brand: amiodarone hci

Generic: amiodarone hci
NDC Package

Package Facts

Identity

Package NDC 51662-1363-1
Digits Only 5166213631
Product NDC 51662-1363
Description

3 mL in 1 VIAL, SINGLE-DOSE (51662-1363-1)

Marketing

Marketing Status
Marketed Since 2019-12-08
Brand amiodarone hci
Generic amiodarone hci
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "ef7bd6e6-d62f-7e93-e053-2a95a90aef83", "openfda": {"upc": ["0363323616038"], "unii": ["976728SY6Z"], "rxcui": ["1663224"], "spl_set_id": ["993b2557-6774-bb7a-e053-2995a90a0503"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "3 mL in 1 VIAL, SINGLE-DOSE (51662-1363-1)", "package_ndc": "51662-1363-1", "marketing_start_date": "20191208"}], "brand_name": "AMIODARONE HCI", "product_id": "51662-1363_ef7bd6e6-d62f-7e93-e053-2a95a90aef83", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1363", "generic_name": "AMIODARONE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMIODARONE HCI", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA075761", "marketing_category": "ANDA", "marketing_start_date": "20191208", "listing_expiration_date": "20261231"}